Digest Network Come funziona
Network
/
Società
Jo
Non verificato

Johnson & Johnson

Di cosa scriviamo

BiotecnologiaFarmaceuticaSaluteSanitàWeb e Social Network

63 comunicati stampa

Guarda tutti i comunicati
21/01/2026
Cardiologia
Biotecnologia
Farmaceutica
Ottica
Oncologia
Salute
Medicina - Varie
Web e Social Network
Telefonia e Varie
Mercato azionario
Johnson & Johnson reports Q4 and Full-Year 2025 results
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
09/01/2026
Politica Interna
Salute
Sanità
Farmaceutica
Biotecnologia
Mercato del lavoro
Johnson & Johnson Reaches Agreement with U.S. Government to Improve Access to Medicines and Lower Costs for Millions of Americans; Delivers on U.S. Manufacturing and Innovation Investments
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
07/01/2026
Salute
Igiene alimentare
Medicina - Varie
Farmaceutica
Biotecnologia
Industria
Johnson & Johnson Submits OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
02/01/2026
Biotecnologia
Sanità
Salute
Farmaceutica
Medicina - Varie
Titoli e azioni
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2026
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
29/12/2026
Mercato azionario
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
Johnson & Johnson completes acquisition of Halda Therapeutics and its novel platform to revolutionize cancer treatment and enable next-generation oral therapies
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
15/12/2025
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Biotecnologia
Sanità
Farmaceutica
Salute
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
08/12/2025
Eventi
Web e Social Network
Biotecnologia
Farmaceutica
Salute
Johnson & Johnson to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
17/11/2025
Mercato azionario
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
Johnson & Johnson Set to Revolutionize the Treatment of Cancer With the Acquisition of Halda Therapeutics
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
05/11/2025
Biotecnologia
Sanità
Farmaceutica
Salute
Web e Social Network
Eventi
Johnson & Johnson to Participate in the Citi’s 2025 Global Healthcare Conference
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
22/10/2025
Web e Social Network
Eventi
Finanza
Biotecnologia
Sanità
Farmaceutica
Salute
Johnson & Johnson to Participate in the 7th Annual Wolfe Research Healthcare Conference
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0